NKX2-5 and differentiated thyroid carcinoma: Nkx2.5 has also been observed to be highly expressed in squamous cell carcinoma of skin (28), T-cell acute lymphoblastic leukemia (30), ovarian yolk sac tumor (29), and papillary thyroid carcinoma (27), while lowly expressed in basal cell carcinoma of skin (28).